KC

Kryger Capital Portfolio holdings

AUM $1.75B Turnover 75%
1-Year Est. Return 102.57%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+102.57%
3 Year Est. Return
+420.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.75B
AUM Growth
+$339M
Cap. Flow
+$244M
Cap. Flow %
13.93%
Top 10 Hldgs %
74.92%
Holding
148
New
72
Increased
20
Reduced
17
Closed
39
Avg Time Held
0.1 years
Top 10 Avg Time Held
0.3 years
Top 20 Avg Time Held
0.2 years

Top Buys

Rank Stock Value
1
NSC icon
Norfolk Southern
NSC
+$72.8M
2
GTLS icon
Chart Industries
GTLS
+$71.1M
3
APGE icon
Apogee Therapeutics
APGE
+$66.9M
4
AES icon
AES
AES
+$66.7M
5
KVUE icon
Kenvue
KVUE
+$58.8M

Top Sells

Rank Stock Value
1
CWAN icon
Clearwater Analytics
CWAN
+$90.3M
2
DAWN icon
Day One Biopharmaceuticals
DAWN
+$83.5M
3
FOLD icon
Amicus Therapeutics
FOLD
+$65.9M
4
HOLX icon
Hologic
HOLX
+$62.1M
5
AL icon
Air Lease Corp
AL
+$57M

Sector Composition

Rank Sector Weight
1 Industrials 24.67%
2 Financials 22.06%
3 Communication Services 18.07%
4 Healthcare 12.34%
5 Consumer Staples 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
DMIIR icon
101
Drugs Made In America Acquisition II Corp Right
DMIIR
$28.6K ﹤0.01%
357,347
-8,354
-2% -$714
2026 Q1
1 quarter
IACOW icon
102
Idea Acquisition Corp Warrants
IACOW
$28.3K ﹤0.01%
+83,265
New +$29.1K
2026 Q2
0 quarters
LPCVW icon
103
Launchpad Cadenza Acquisition Corp I Warrant
LPCVW
$2.26M
$26.4K ﹤0.01%
+67,602
New +$22.2K
2026 Q2
0 quarters
MZYX.WS icon
104
MOZAYYX Acquisition Corp Warrants
MZYX.WS
$19.4K ﹤0.01%
+27,628
New +$12.7K
2026 Q2
0 quarters
ITHAW icon
105
ITHAX Acquisition Corp III Warrants
ITHAW
$18.2K ﹤0.01%
+75,675
New +$16.5K
2026 Q2
0 quarters
SORNW icon
106
Soren Acquisition Corp Warrant
SORNW
$16.3K ﹤0.01%
+56,507
New +$15.8K
2026 Q2
0 quarters
MESHW icon
107
Meshflow Acquisition Corp Warrants
MESHW
$1.84M
$12.7K ﹤0.01%
+42,394
New +$12.3K
2026 Q2
0 quarters
MBVIW icon
108
M3-Brigade Acquisition VI Corp Warrant
MBVIW
$10.4K ﹤0.01%
+25,888
New +$9.53K
2026 Q2
0 quarters
BLZRW icon
109
Trailblazer Acquisition Corp Warrant
BLZRW
$3.42K ﹤0.01%
+8,553
New +$3.55K
2026 Q2
0 quarters
AL icon
110
DELISTED
Air Lease Corp
AL
– –
-878,107
Closed -$57M –
APLS icon
111
DELISTED
Apellis Pharmaceuticals
APLS
– –
-1,100,000
Closed -$44.3M –
BA icon
112
Boeing
BA
$146B
– –
-25,000
Closed -$4.98M –
CWAN icon
113
DELISTED
Clearwater Analytics
CWAN
– –
-3,817,188
Closed -$90.3M –
DAWN icon
114
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-3,896,485
Closed -$83.5M –
FOLD icon
115
DELISTED
Amicus Therapeutics
FOLD
– –
-4,554,174
Closed -$65.9M –
GLD icon
116
SPDR Gold Trust
GLD
$139B
– –
-15,000
Closed -$6.45M –
HOLX icon
117
DELISTED
Hologic
HOLX
– –
-821,131
Closed -$62.1M –
MASI icon
118
DELISTED
Masimo
MASI
– –
-100,589
Closed -$17.9M –
RIOT icon
119
Riot Platforms
RIOT
$5.67B
– –
-239,039
Closed -$2.95M –
RVMD icon
120
Revolution Medicines
RVMD
$41.5B
– –
-8,670
Closed -$843K –
UDMY icon
121
DELISTED
Udemy
UDMY
– –
-99,277
Closed -$459K –
VAL icon
122
Valaris
VAL
$5.88B
– –
-3,065
Closed -$300K –
OS
123
DELISTED
OneStream Inc
OS
– –
-201,986
Closed -$4.85M –
LFACU icon
124
Leapfrog Acquisition Corp Units
LFACU
– –
-332,310
Closed -$3.34M –
DSACU icon
125
Daedalus Special Acquisition Corp Unit
DSACU
– –
-70,887
Closed -$711K –
2 3 4
5
6

Similar funds

L7C
Liberty 77 Capital Washington, District of Columbia $1.75B AUM 88.73% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.75B AUM 33.61% 1-Year Est. Return
FTS
Fifth Third Securities Cincinnati, Ohio $1.75B AUM 21.97% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.75B AUM 41.21% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.75B AUM 57.75% 1-Year Est. Return
AG
Atairos Group Bryn Mawr, Pennsylvania $1.76B AUM 16.47% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
ACG
Aventail Capital Group New York $1.74B AUM 49.22% 1-Year Est. Return

Kryger Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Kryger Capital held 148 positions worth $1.75B, up 24% from $1.41B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Kryger Capital deployed $244M of net new capital in Q2 2026, opening 72 new positions and adding to 20 existing holdings. Its largest new stake was Apogee Therapeutics: 742,555 shares worth $98.6M.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 23% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Penumbra, an estimated $15.1M trimmed.

  • Kryger Capital's largest Q2 2026 buy was Apogee Therapeutics: 742,555 shares worth $98.6M.
  • Kryger Capital added most to Norfolk Southern in Q2 2026, an estimated $72.8M increase.
  • Kryger Capital's biggest Q2 2026 reduction was Penumbra, cutting an estimated $15.1M.
  • Kryger Capital fully exited Clearwater Analytics in Q2 2026, selling an estimated $90.3M.
  • Kryger Capital's ten largest holdings make up 75% of its $1.75B portfolio in Q2 2026.
  • Kryger Capital opened 72 new positions and closed 39 in Q2 2026.
  • Kryger Capital's portfolio value rose 24% quarter-over-quarter to $1.75B.

Based on Kryger Capital's 13F filing for Q2 2026, filed 14 Aug 2026.